跳至主要内容
临床试验/NCT07690696
NCT07690696尚未招募不适用

Novel Diagnostic and Treatment Response Biomarkers in Tear Fluid of Migraine Patients

Fondazione Policlinico Universitario Agostino Gemelli IRCCS0 个研究点目标入组 400 人开始时间: 2026年9月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
400
主要终点
Differences in tear biomarker

研究概览

简要总结

The goal of this observational monocentric study is to investigate tear and serum biomarkers in patients with migraine compared with healthy controls, and to explore their potential diagnostic, clinical, and predictive value. In addition to the cross-sectional evaluation, a longitudinal subgroup analysis will be conducted to assess biomarker changes over time during treatment with anti- Calcitonin Gene-Related Peptide (anti-CGRP) therapies.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with migraine
  • Male or female participants aged ≥ 18 years;
  • Diagnosis of migraine according to International Classification of Headache Disorders (ICHD) criteria;
  • Clinical indication, according to routine practice, for treatment with anti-CGRP monoclonal antibodies or gepants (only for the longitudinal subgroup);
  • Ability and willingness to provide written informed consent. Inclusion criteria for healthy controls
  • Male or female participants aged ≥ 18 years;
  • Subjects, without migraine;
  • Ability and willingness to provide written informed consent.

排除标准

  • (for both patients with migraine and healthy controls)
  • Fulfillment of ICHD diagnostic criteria for secondary headaches;
  • Active inflammatory ocular diseases;
  • Severe abnormalities in tear production;
  • Systemic inflammatory diseases that may interfere with biomarker interpretation.

研究组 & 干预措施

Patients with migraine

Patients with migraine

干预措施: Patients with migraine (Diagnostic Test)

Healthy controls

Healthy controls

结局指标

主要结局

Differences in tear biomarker

时间窗: Through the study completion, about 3 years

Differences in tear levels between patients with migraine and healthy controls of the following biomarkers: Calcitonin Gene-Related Peptide (CGRP), pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), Interleukin 10 (IL-10), Interleukin 1β (IL-1β), Tumor necrosis factor-α (TNF-α).

次要结局

  • Correlations between tear biomarkers and clinical features of migraine(Through the study completion, about 3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vollono Catello

Neurologist

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

相似试验